long covid

Abstract Most of the people who suffered from COVID-19 fully recovered, but approximately 10–20% of them developed a wide variety of symptoms after they recover from their initial illness. Long COVID can develop at any patient; however, several studies suggest that the development of Long Covid...

First major survey of doctors with Long Covid reveals debilitating impact on health, life and work by BMA media team Press release from the BMA Location: UK Published: Tuesday 4 July 2023 Key findings include: Doctors reported a wide range of symptoms, including fatigue, headaches, muscular...

The role of adaptive immune responses in long COVID remains poorly understood, with contrasting hypotheses suggesting either an insufficient antiviral response or an excessive immune response associated with inflammatory damage. To address this issue, we set to characterize humoral and CD4+ T...

Genome-wide Association Study of Long COVID, Lammi, Ollila et al 2023 Abstract Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections(1,2). Similarly...

Pre-pandemic activity on a myalgic encephalomyelitis/chronic fatigue syndrome support forum is highly associated with later activity on a long COVID support forum for a variety of reasons: a mixed methods study. William U Meyerson; Rick H Hoyle Encephalomyelitis/chronic fatigue syndrome...

‘I am just a shadow of who I used to be’—Exploring existential loss of identity among people living with chronic conditions of Long COVID Chao Fang; Sarah Akhtar Baz; Laura Sheard; JD Carpentieri Identity loss and (re)construction forms a central debate in sociology of chronic illness. Living...

High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long-COVID: Implications for management and healthcare planning Marie-Claire Seeley; Celine Gallagher; Eric Ong; Amy Langdon; Jonathan Chieng; Danielle Bailey; Amanda Page; Han S. Lim; Dennis H...

3 Years Into Long COVID: Where Do We Go From Here? https://www.medscape.com/viewarticle/993827 "... approximately 6% of all US adults are currently experiencing long COVID, with Hispanic/Latinx individuals, transgender individuals, and cis female individuals facing the highest rates."...

Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis Sobrino-Relaño, Saioa; Balboa-Bandeira, Yolanda; Peña, Javier; Ibarretxe-Bilbao, Naroa; Zubiaurre-Elorza, Leire; Ojeda, Natalia Long-term persistent symptoms of COVID-19 affect...

Long COVID Rehabilitation: A Guide for Health Care Professionals $199 Long Covid Rehabilitation: A Guide for Healthcare Professionals is a comprehensive online course designed to provide rehabilitation professionals with the knowledge and skills necessary to effectively treat patients with Long...

A Molecular Biomarker-Based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms Paul Guest et al paywalled Abstract Approximately 30% of COVID-19 cases may experience chronic symptoms, known as post-COVID-19...

Full title: Cognitive impairment in post-acute sequelae of COVID-19 and short duration myalgic encephalomyelitis patients is mediated by orthostatic hemodynamic changes Introduction: Cognitive impairment is experienced by people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...

Long COVID: The impact on language and cognition Louise Cummings Abstract COVID-19 continues to have profound health and economic consequences around the world. Aside from the large number of deaths from this viral infection, there is a growing population of individuals who have not made a good...

From May 2023 https://www.generali.co.uk/Media/Podcasts.html article and partial transcript here https://www.hrgrapevine.com/content/article/from-long-covid-to-me-chronic-fatigue-syndrome-cfs-latest-trends-employer-support-generali-uk-employee-benefits

What’s New in the Search for a Long COVID Cure? Effective therapies that target the condition’s root causes could be a few years away. Interviewing Michael Peluso, most recently author of Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary...

Comorbidity genetic risk and pathways impact SARS-CoV-2 infection outcomes Jaros, Rachel K.; Fadason, Tayaza; Cameron-Smith, David; Golovina, Evgeniia; O’Sullivan, Justin M. Understanding the genetic risk and mechanisms through which SARS-CoV-2 infection outcomes and comorbidities interact to...

Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease One in ten SARS-CoV-2 infections result in prolonged symptoms termed ‘long COVID’, yet disease phenotypes and mechanisms are poorly understood. We studied the blood proteome of 719 adults, grouped by...

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors Fiedler, Lukas; Motloch, Lukas J.; Dieplinger, Anna-Maria; Jirak, Peter...

The actual study start date was March 2023, the estimated primary end date was 1 June 2023 and the estimated study completion date is 1 October 2023. Clinical Trials link: https://clinicaltrials.gov/ct2/show/NCT05813587?term=Meplazumab&draw=2&rank=8 Randomized, double-blind...

Long COVID: Costs for the German economy and health care and pension system Gandjour, Afschin Background Patients with acute COVID-19 can develop persistent symptoms (long/post COVID-19 syndrome). This study aimed to project the economic, health care, and pension costs due to long/post-COVID-19...